| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 06/25/1997 | EP0780387A1 Thiophene compounds, process for their preparation and pharmaceutical compositions containing them |
| 06/25/1997 | EP0780386A1 Matrix metalloprotease inhibitors |
| 06/25/1997 | EP0780379A1 A 4-imidazolidinone derivative and its use as NMDA receptor agonist |
| 06/25/1997 | EP0780128A2 Crotonic acid amide derivatives and lipoprotein containing compositions |
| 06/25/1997 | EP0780055A2 Nutritional coffee composition |
| 06/25/1997 | EP0779820A1 Bioadhesive-wound healing composition |
| 06/25/1997 | EP0779819A1 Therapeutic treatment of clostridium difficile associated diseases |
| 06/25/1997 | EP0779816A1 Use of insulin-like growth factors (i) and (ii) for inhibition of inflammatory response |
| 06/25/1997 | EP0779813A1 Phosphonates and parathyroid hormone for osteoporosis |
| 06/25/1997 | EP0779812A1 Methods for the treatment of osteoporosis using bone active phosphonates and parathyroid hormone |
| 06/25/1997 | EP0779809A1 Use of selegiline to prolong life span |
| 06/25/1997 | EP0779808A1 Triphenylethylenes for the prevention and treatment of osteoporosis |
| 06/25/1997 | EP0696199A4 Amidino and guanidino substituted boronic acid inhibitors of trypsin-like enzymes |
| 06/25/1997 | CN1152920A Palladium catalyzed ring closure of triazolyl tryptamine |
| 06/25/1997 | CN1152910A Difluorostatone antiviral agents |
| 06/25/1997 | CN1152875A Enhanced virus-mediated DNA transfer |
| 06/25/1997 | CN1152874A Copolymer-1 improvements in compositions of copolymers |
| 06/25/1997 | CN1152871A Methods of use for peroxynitrite decompositionc atalysts, pharmaceutical compositions therefor |
| 06/25/1997 | CN1152869A Treatment for atherosclerosis and other cardiovascular and inflammatory diseases |
| 06/25/1997 | CN1152865A Methods of lightening hyperpigmented regions in mammalian skin |
| 06/25/1997 | CN1035257C Midified plutelet factor-4 |
| 06/24/1997 | US5641867 Antitumor agents |
| 06/24/1997 | US5641814 Antikeratolytic-wound healing compositions and methods for preparing and using same |
| 06/24/1997 | US5641800 Alleviate effect of septic shock, adult respiratory distress syndrome, pancreatitis, trauma, bronchial asthma, allergic rhinitis, and rheumatoid arthritis |
| 06/24/1997 | US5641797 6-heterocyclic-4-amino-1,3,4,5-tetrahydrobenz[cd] indoles |
| 06/24/1997 | US5641793 Pyridine compounds which have useful pharmaceutical activity |
| 06/24/1997 | US5641792 Benzoylguanidines substituted by heterocyclic N-oxide, process for their preparation and pharmaceutical compositions containing them |
| 06/24/1997 | US5641790 Pharmaceutical formulation in low dosage unit form containing 2-phenyl-3-aroylbenzothiophene derivative |
| 06/24/1997 | US5641789 Sulfonamide derivatives of benzenefused hydroxy substituted cycloalkyl and heterocyclic ring compounds |
| 06/24/1997 | US5641779 Selective ligands of 5-HT1D -5-HT1B receptors derived from indolepiperazine which are useful medicaments |
| 06/24/1997 | US5641777 Neurokinin receptor antagonist |
| 06/24/1997 | US5641774 Compounds useful as antiproliferative agents and garft inhibitors |
| 06/24/1997 | US5641771 Compounds useful as antiproliferative agents and garft inhibitors |
| 06/24/1997 | US5641670 Protein production and protein delivery |
| 06/24/1997 | US5641669 Platelet-activating factor acetylhydrolase |
| 06/24/1997 | US5641657 DNA encoding an interleukin-6 splice variant |
| 06/24/1997 | US5641653 Producing antigens used for vaccinating pigs against pleuropneumonia |
| 06/24/1997 | US5641625 Peptide nucleic acids forming duplex, triplex and other structures with nucleic acids; modulation of protein activity by transcription arrest and initiation; specific site cleavage |
| 06/24/1997 | US5641475 Antiodor, antimicrobial and preservative compositions and methods of using same |
| 06/22/1997 | CA2193610A1 17 .alpha.-cyanomethylestra-4, 9-dien derivative compounds, processes for making same and pharmaceutical compositions containing same |
| 06/22/1997 | CA2193308A1 New thiophene compounds; process for preparing the same and pharmaceutical compositions containing them |
| 06/20/1997 | CA2193315A1 Human mucin (muc8) |
| 06/19/1997 | WO1997021826A2 Complementary adenoviral vector systems and cell lines |
| 06/19/1997 | WO1997021820A2 A novel protein kinase required for ras signal transduction |
| 06/19/1997 | WO1997021726A1 Agents for promoting bone formation |
| 06/19/1997 | WO1997021725A1 3-aminoethyl-n-amidino-2,5-dihydropyrrole derivatives having arginine mimetic properties |
| 06/19/1997 | WO1997021707A1 Antagonists of gonadotropin releasing hormone |
| 06/19/1997 | WO1997021704A1 Antagonists of gonadotropin releasing hormone |
| 06/19/1997 | WO1997021703A1 Antagonists of gonadotropin releasing hormone |
| 06/19/1997 | WO1997021702A1 3-benzylaminopyrrolidines and -piperidines as tachykinin receptor antagonists |
| 06/19/1997 | WO1997021701A1 Farnesyl protein transferase inhibiting (imidazol-5-yl)methyl-2-quinolinone derivatives |
| 06/19/1997 | WO1997021690A1 D-amino acid derived inhibitors of cysteine and serine proteases |
| 06/19/1997 | WO1997021685A1 Retroviral protease inhibiting compounds |
| 06/19/1997 | WO1997021682A1 3-pyrazolecarboxamide derivatives having cannabinoid receptor affinity |
| 06/19/1997 | WO1997021676A1 Azetidinone compounds for the treatment of atherosclerosis |
| 06/19/1997 | WO1997021675A1 Monocyclic beta-lactame derivatives for treatment of atherosclerosis |
| 06/19/1997 | WO1997021665A1 Arylethanolamine derivatives and their use as agonists of atypical beta-adrenoceptors |
| 06/19/1997 | WO1997021664A1 NAPHTHYL ACETAMIDES AS sPLA2 INHIBITORS |
| 06/19/1997 | WO1997021447A1 Compositions and therapeutic methods using morphogenic proteins and stimulatory factors |
| 06/19/1997 | WO1997021444A1 Cytokine and hemopoietic factor endogenous production enhancer and methods of use thereof |
| 06/19/1997 | WO1997021439A1 Medicament intended to the treatment of obsessive compulsive troubles, sleep apnoea, sexual dysfunctions, emesa and transport sickness |
| 06/19/1997 | CA2509505A1 Retroviral protease inhibiting compounds |
| 06/19/1997 | CA2273983A1 Process for the preparation of 9-deazaguanine derivatives |
| 06/19/1997 | CA2240395A1 Naphthyl acetamides as spla2 inhibitors |
| 06/19/1997 | CA2240111A1 Antagonists of gonadotropin releasing hormone |
| 06/19/1997 | CA2240108A1 Antagonists of gonadotropin releasing hormone |
| 06/19/1997 | CA2240048A1 Antagonists of gonadotropin releasing hormone |
| 06/19/1997 | CA2239908A1 3-aminoethyl-n-amidino-2,5-dihydropyrrole derivatives having arginine mimetic properties |
| 06/19/1997 | CA2239874A1 Cytokine and hemopoietic factor endogenous production enhancer and methods of use thereof |
| 06/19/1997 | CA2238711A1 3-benzylaminopyrrolidines and piperidines as tachykinin receptor antagonists |
| 06/19/1997 | CA2238175A1 D-amino acid derived inhibitors of cysteine and serine proteases |
| 06/19/1997 | CA2236335A1 Agents for promoting bone formation |
| 06/19/1997 | CA2211161A1 Medicament intended to the treatment of obsessive compulsive troubles, sleep apnoea, sexual dysfunctions, emesa and transport sickness |
| 06/18/1997 | EP0779291A1 Heterocyclylcarbonyl substituted benzofuranyl-ureas |
| 06/18/1997 | EP0779284A1 Novel 2-naphthamide derivatives and their use in therapy as D3 receptor agonists |
| 06/18/1997 | EP0779271A1 Naphthyl acetamides as sPLA2 inhibitors |
| 06/18/1997 | EP0779076A1 Peptide, a method of obtaining it and a pharmaceutical compound based on it |
| 06/18/1997 | EP0778892A1 Macrophage derived chemokine and chemokine analogs |
| 06/18/1997 | EP0778848A1 Agents for inducing apoptosis and applications of said agents in therapy |
| 06/18/1997 | EP0778843A1 Intermediates for dinucleotide and oligonucleotide analogues |
| 06/18/1997 | EP0778835A1 7-azabicyclo 2.2.1]-heptane and -heptene derivatives as cholinergic receptor ligands |
| 06/18/1997 | EP0778834A1 Diaryl bicyclic heterocycles as inhibitors of cyclooxygenase-2 |
| 06/18/1997 | EP0778833A1 Endothelin receptor antagonists |
| 06/18/1997 | EP0778831A1 Morpholine derivatives and their use as therapeutic agents |
| 06/18/1997 | EP0778820A1 Neurotrophic and antiproliferative compounds |
| 06/18/1997 | EP0778776A1 Hyaluronic acid and derivatives for modulation of cellular activity |
| 06/18/1997 | EP0778768A1 Formulations and methods for providing prolonged local anesthesia |
| 06/18/1997 | EP0687257B1 4-amino-2-(hetero)aryl-butanamides useful as 5-ht1a-antagonists |
| 06/18/1997 | EP0662953B1 Novel vitamin d analogues |
| 06/18/1997 | EP0616609B1 Nitroaniline derivatives and their use as antitumor agents |
| 06/18/1997 | EP0559706B1 2$g(b),19-METHYLENEAMINO BRIDGED STEROIDS AS AROMATASE INHIBITORS |
| 06/18/1997 | EP0494264B1 Inhibiting transforming growth factor to prevent accumulation of extracellular matrix |
| 06/18/1997 | CN1152337A Superoxide dismutase-4 |
| 06/18/1997 | CN1152313A Process for preparation of 2-(1-azabicyclo(2,2,2)oct-3-yl)-2,4,5,6-tetrahydro-1H-benz (DE)isoquinolin-1-1one and intermediate product |
| 06/18/1997 | CN1152304A Substituted benzamidines, their production and their use as medicaments |
| 06/18/1997 | CN1152303A Novel chemical compound, its preparation and use as drug |
| 06/18/1997 | CN1152302A Retinoic acid X-receptor ligands |
| 06/18/1997 | CN1151893A Combination antiemetic therapy using NK-1 receptor antagonists |
| 06/18/1997 | CN1035177C Prep. of 20-methyl-substituted vitamin D-derivatives |
| 06/17/1997 | US5639887 MDR reversal agents |